Shortsea shipping specialist CLdN if offering a pooling service to allow shipping industry stakeholders to meet more rigorous ...

今日，信达生物宣布，公司IBI343再次被中国国家药品监督管理局（NMPA）药品评审中心（CDE）纳入突破性治疗药物（BTD）品种名单，拟定适应症为至少 ...

1月15日，Axcynsis Therapeutics Pte ...

美国旧金山和中国苏州2025年1月16日 /美通社/ -- 信达生物制药集团（香港联交所股票代码：01801），一家致力于研发、生产和 ...

Shipowner CLdN has launched a pooling venture to partner with peers in meeting new European Union rules on greenhouse gas ...

CLdN offers pooling services to support FuelEU Maritime compliance. Find the latest news from the maritime industry on the PortNews website.

Bunkerspot provides news, in-depth analysis, expert comment and price indications for the global marine fuels industry ...

The US FDA has started a fresh review of Astellas' zolbetuximab, trying to become the first claudin (CLDN) 18.2-targeting drug to reach the US market, after turning it down earlier this year.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Antennova, a clinical-stage biotech company focused on oncology today announced the presentation of latest data from its Phase I/II CLINCH study ongoing in China and Australia evaluating ATN-022 ...